NCT04554446

Brief Summary

This study is a single blind, randomized controlled trial. condition/disease: acute low-back pain treatment/intervention: Motion Style Acupuncture Treatment using Traction (T-MSAT)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Sep 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 7, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

September 18, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

September 21, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2021

Completed
Last Updated

July 6, 2021

Status Verified

July 1, 2021

Enrollment Period

6 months

First QC Date

September 7, 2020

Last Update Submit

July 1, 2021

Conditions

Keywords

acupuncture therapy

Outcome Measures

Primary Outcomes (1)

  • Numeric Rating Scale(NRS) of low-back pain

    The extent of acute low-back pain and discomfort was assessed using NRS. NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10. The participants are asked to report their low-back pain and discomfort using NRS, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

    Change from baseline VAS at 4 days

Secondary Outcomes (16)

  • Numeric Rating Scale(NRS) of low-back pain

    baseline(day1), day2, day3, day4, day of Discharge(up to 14days), week 12

  • Visual Analogue Scale (VAS) of low-back pain

    Baseline, day3, day4, day of discharge(up to 14days)

  • Visual Analogue Scale (VAS) of leg pain

    Baseline, day3, day4, day of discharge(up to 14days)

  • Numeric Rating Scale(NRS) of leg pain

    Baseline, day3, day4, day of discharge(up to 14days), week12

  • Range of movement (ROM) of flexion

    Baseline, day3, day4, day of discharge(up to 14days)

  • +11 more secondary outcomes

Study Arms (2)

T-MSAT(Motion style acupuncture treatment using Traction)

EXPERIMENTAL

T-MSAT group receives 3 sessions of T-MSAT; on 2nd, 3rd, 4th day after hospitalization. A trained doctor of Korean medicine with clinical experience conducted the T-MSAT. And T-MSAT group is also treated with other Korean integrative medicine treatment everyday: acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

Procedure: T-MSAT(Motion style acupuncture treatment using traction)Procedure: Korean medicine treatment

Korean medicine treatment

ACTIVE COMPARATOR

The control group is received Korean integrative medicine treatment everyday; acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

Procedure: Korean medicine treatment

Interventions

Motion Style Acupuncture Treatment(MSAT) is a therapeutic technique using acupuncture needle created in Jaseng Hospital. T-MSAT(Motion style acupuncture treatment using traction) is a kind of MSATs, and a treatment that improves musculoskeletal problems by pulling the patient's body through the device and giving instructions for walking while being acupuncture.

T-MSAT(Motion style acupuncture treatment using Traction)

acupuncture, chuna, pharmacoacupuncture and Korean herbal medicine.

Korean medicine treatmentT-MSAT(Motion style acupuncture treatment using Traction)

Eligibility Criteria

Age19 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 19-70 years on the date they sign the consent form
  • Patients with NRS ≥ 5 for low-back pain
  • Patients who needs hospitalization due to acute low-back pain that occurred within 7 days after traffic accident
  • Patients who provide consent to participate in the trial and return the informed consent form

You may not qualify if:

  • Patients with a specific serious disease that may cause acute low-back pain: malignancy, fracture of lumbar spine, etc.
  • Patients with progressive neurological deficits or with severe neurological symptoms
  • The cause of pain is due to soft tissue disease, not the spine: tumors, fibromyalgia, rheumatoid arthritis, gout, etc.
  • Patients with other chronic conditions that may interfere with the interpretation of the therapeutic effects or results: cardiovascular disease, kidney disease, diabetic neuropathy, dementia, epilepsy, etc.
  • Patients who are difficult to walk due to leg disorder unrelated to low-back pain
  • Patients who are taking steroids, immunosuppressants, mental illness drugs, or other drugs that may affect the results of the study
  • Patients who are pregnant, planning to become pregnant, or are breastfeeding
  • Patients who have had surgery or procedures of lumbar spine within the last three weeks
  • Patients with a serious mental illness
  • Patients who are participated in clinical trials other than observational studies without therapeutic intervention.
  • Patients who are difficult to complete the research participation agreement
  • Other patients whose participation in the trial is judged by a researcher to be problematic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jaseng Hospital of Korean Medicine

Seoul, Gangnam-Gu, 135-896, South Korea

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • In-Hyuk Ha, Dr.

    Jaseng Medical Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

September 7, 2020

First Posted

September 18, 2020

Study Start

September 21, 2020

Primary Completion

March 18, 2021

Study Completion

June 21, 2021

Last Updated

July 6, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share

Locations